{
    "moduleId": "module_10",
    "moduleTitle": "L1 Deep Dive Module 10: Advanced Reproductive Transitions & Longevity",
    "passingScore": 80,
    "questions": [
        {
            "id": "q10_1",
            "question": "During the late perimenopausal transition, what is the primary neuroendocrine mechanism responsible for the significant rise in Follicle Stimulating Hormone (FSH)?",
            "options": [
                "A decrease in Inhibin-B production by the depleting ovarian follicle pool",
                "An increase in Kisspeptin signaling in the arcuate nucleus",
                "The direct stimulatory effect of rising progesterone on the pituitary",
                "A decrease in GnRH pulse frequency from the hypothalamus"
            ],
            "correctAnswer": 0,
            "explanation": "As the ovarian follicle pool depletes, the production of Inhibin-B decreases. Since Inhibin-B normally provides negative feedback to the pituitary to suppress FSH, its decline leads to the characteristic rise in FSH seen in perimenopause."
        },
        {
            "id": "q10_2",
            "question": "Which of the following best describes 'Relative Estrogen Dominance' in a perimenopausal client?",
            "options": [
                "The client has serum estradiol levels exceeding 400 pg/mL consistently",
                "Estrogen levels are within normal range or low, but progesterone is insufficient to antagonize estrogen's effects",
                "The complete cessation of estrogen production by the ovaries",
                "A condition caused exclusively by the ingestion of xenoestrogens from the environment"
            ],
            "correctAnswer": 1,
            "explanation": "Relative estrogen dominance occurs when progesterone levels drop significantly (often due to anovulatory cycles), leaving even low or 'normal' levels of estrogen unopposed, leading to symptoms like heavy bleeding and breast tenderness."
        },
        {
            "id": "q10_3",
            "question": "According to Lesson 3, the shift from a gynoid to an android fat distribution during menopause is primarily driven by which metabolic change?",
            "options": [
                "A decrease in total caloric expenditure by 50%",
                "The upregulation of GLUT4 transporters in peripheral muscle tissue",
                "Reduced estradiol signaling leading to increased Lipoprotein Lipase (LPL) activity in visceral adipocytes",
                "Increased sensitivity to insulin in the subcutaneous fat compartments"
            ],
            "correctAnswer": 2,
            "explanation": "Estradiol normally inhibits Lipoprotein Lipase (LPL) in the visceral area. When estradiol declines, LPL activity increases in the abdominal region, promoting the storage of visceral fat (android distribution)."
        },
        {
            "id": "q10_4",
            "question": "In the context of the 'Menopausal Brain,' why does the decline in estrogen often lead to significant sleep architecture disruption?",
            "options": [
                "Estrogen is the only hormone responsible for melatonin production",
                "Declining estrogen narrows the thermoregulatory zone, leading to nocturnal cortisol spikes and vasomotor symptoms",
                "Progesterone increases sharply at night during menopause, causing alertness",
                "The brain enters a state of permanent hyper-glycemia during the night"
            ],
            "correctAnswer": 1,
            "explanation": "Estrogen helps maintain a wide thermoregulatory zone in the hypothalamus. As it declines, the zone narrows, meaning small changes in core temperature trigger 'heat dissipation' responses (hot flashes/night sweats), which spike cortisol and disrupt sleep."
        },
        {
            "id": "q10_5",
            "question": "A 2023 meta-analysis discussed in Lesson 5 indicates that women can lose up to what percentage of their bone mineral density (BMD) during the first five years of menopause?",
            "options": [
                "2-3%",
                "5-7%",
                "10-20%",
                "40-50%"
            ],
            "correctAnswer": 2,
            "explanation": "The rapid decline in estradiol leads to an imbalance in bone remodeling, where osteoclast activity (resorption) significantly outpaces osteoblast activity, resulting in a 10-20% loss of BMD in the early postmenopausal years."
        },
        {
            "id": "q10_6",
            "question": "The 'Window of Opportunity' hypothesis for Hormone Replacement Therapy (HRT) suggests that cardiovascular benefits are most significant when treatment is initiated:",
            "options": [
                "At least 20 years after the final menstrual period",
                "Only after the age of 70 to prevent stroke",
                "Within 10 years of menopause onset or before age 60",
                "Exclusively in the pre-perimenopausal stage (age 35-40)"
            ],
            "correctAnswer": 2,
            "explanation": "Research indicates that HRT has a cardioprotective effect when started early (the 'window'); starting it much later, when atherosclerosis is already established, may increase risks rather than provide benefits."
        },
        {
            "id": "q10_7",
            "question": "Which symptom is a hallmark of Genitourinary Syndrome of Menopause (GSM) but was often overlooked in the older 'vaginal atrophy' diagnosis?",
            "options": [
                "Occasional hot flashes",
                "Urinary urgency and increased frequency of UTIs",
                "Increased scalp hair growth",
                "Improvement in skin elasticity"
            ],
            "correctAnswer": 1,
            "explanation": "GSM is a comprehensive term that includes not just vaginal dryness but also urinary symptoms like urgency, dysuria, and recurrent UTIs, due to the high density of estrogen receptors in the bladder and urethra."
        },
        {
            "id": "q10_8",
            "question": "To effectively combat sarcopenia and support muscle protein synthesis (MPS) in a postmenopausal client, what is the recommended daily protein intake discussed in Lesson 8?",
            "options": [
                "0.6g per kg of body weight",
                "0.8g per kg of body weight (Standard RDA)",
                "1.2g to 1.5g per kg of body weight",
                "Protein intake does not matter as long as calories are low"
            ],
            "correctAnswer": 2,
            "explanation": "Postmenopausal women face 'anabolic resistance.' To overcome this and maintain muscle mass, they require higher protein intakes (1.2-1.5g/kg) than the standard RDA, ideally with 25-30g of high-quality protein per meal."
        },
        {
            "id": "q10_9",
            "question": "Case Study: Jane, age 52, has not had a period for 14 months. She reports brain fog and joint pain. Her DEXA scan shows a T-score of -1.5. How should this T-score be interpreted?",
            "options": [
                "Normal bone density",
                "Osteopenia",
                "Severe Osteoporosis",
                "Paget's Disease"
            ],
            "correctAnswer": 1,
            "explanation": "A T-score between -1.0 and -2.5 is classified as osteopenia, indicating low bone mass that is not yet at the level of osteoporosis but requires intervention to prevent further loss."
        },
        {
            "id": "q10_10",
            "question": "In coaching a client through the perimenopausal transition, why is 'Blood Sugar Stability' considered a priority longevity strategy?",
            "options": [
                "Because estrogen increases insulin sensitivity, and its decline makes the body more prone to insulin resistance",
                "Because sugar is the only fuel source the menopausal brain can use",
                "Because high blood sugar prevents hot flashes from occurring",
                "Because insulin resistance is required to produce progesterone"
            ],
            "correctAnswer": 0,
            "explanation": "Estradiol enhances insulin sensitivity and GLUT4 translocation. As estradiol drops, women become more insulin resistant, making blood sugar management critical to prevent weight gain, metabolic syndrome, and cognitive decline."
        }
    ]
}